Jacobs Levy Equity Management Inc. Raises Stock Position in Astrana Health, Inc. $ASTH

Jacobs Levy Equity Management Inc. increased its holdings in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 211.6% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 237,926 shares of the company's stock after acquiring an additional 161,580 shares during the quarter. Jacobs Levy Equity Management Inc. owned about 0.42% of Astrana Health worth $7,378,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Northern Trust Corp boosted its holdings in shares of Astrana Health by 10.1% during the 4th quarter. Northern Trust Corp now owns 467,179 shares of the company's stock worth $14,730,000 after purchasing an additional 43,032 shares during the last quarter. Bank of America Corp DE boosted its stake in Astrana Health by 44.2% during the fourth quarter. Bank of America Corp DE now owns 97,721 shares of the company's stock worth $3,081,000 after buying an additional 29,971 shares during the last quarter. Centiva Capital LP purchased a new stake in Astrana Health in the 4th quarter valued at $355,000. Graham Capital Management L.P. purchased a new stake in Astrana Health in the 4th quarter valued at $741,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Astrana Health by 3.9% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 24,505 shares of the company's stock worth $773,000 after acquiring an additional 915 shares during the last quarter. Institutional investors and hedge funds own 52.77% of the company's stock.

Astrana Health Trading Down 1.1%

Shares of ASTH traded down $0.32 during trading on Friday, reaching $30.06. 104,762 shares of the company traded hands, compared to its average volume of 339,975. The stock has a 50-day simple moving average of $26.87 and a 200-day simple moving average of $28.02. The stock has a market cap of $1.69 billion, a PE ratio of 58.94, a price-to-earnings-growth ratio of 0.72 and a beta of 0.85. Astrana Health, Inc. has a twelve month low of $21.20 and a twelve month high of $63.20. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.52.

Astrana Health (NASDAQ:ASTH - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.19 earnings per share for the quarter, missing analysts' consensus estimates of $0.36 by ($0.17). The company had revenue of $654.81 million for the quarter, compared to analysts' expectations of $639.13 million. Astrana Health had a return on equity of 3.43% and a net margin of 1.04%.The business's revenue for the quarter was up 34.7% on a year-over-year basis. During the same period in the previous year, the business posted $0.40 EPS. Astrana Health has set its Q3 2025 guidance at EPS. On average, analysts anticipate that Astrana Health, Inc. will post 1.15 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, Zacks Research lowered shares of Astrana Health from a "strong-buy" rating to a "strong sell" rating in a report on Monday, September 1st. Six analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $53.29.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.